Thyroid News

CHICAGO — The era of untreatable anaplastic thyroid cancer is progressively being replaced by highly specific molecularbased personalized therapy, according to a presenter at the Annual Meeting of the American Thyroid Association.

CHICAGO — Investigators from The Ohio State University Comprehensive Cancer Center have initiated research on the proteomic gene alterations in medullary thyroid cancer to develop better targeted therapies for this patient population, according to data presented at the Annual Meeting of the American Thyroid Association.

CHICAGO — The American Thyroid Association will publish new guidelines on ethical, surgical and medical considerations for patients with anaplastic thyroid cancer, according to speakers at the Annual Meeting of the American Thyroid Association.

CHICAGO — Bryan R. Haugen, MD, professor of medicine in the department of medicine-endocrinology, metabolism and diabetes at the University of Colorado School of Medicine received the 2019 Sydney H. Ingbar award during the Annual Meeting of the American Thyroid Association.

CHICAGO—Compounded oral liquid levothyroxine products vary in stability, potency and consistency and present risks for patients, according to data presented the American Thyroid Association annual meeting.

CHICAGO — In this video exclusive, Endocrine Today Editorial Board Member Stephanie L. Lee, MD, PhD, FACE, ECNU, professor of medicine and director of thyroid health in the section of endocrinology, diabetes and nutrition at Boston Medical Center, discusses machine-learning programs for assessing thyroid nodules.

CHICAGO — In a cohort of adults who received a thyroid function test during hospitalization, most did not have a thyroid disease and those who did generally had mild conditions, according to findings presented at the annual meeting of the American Thyroid Association.

CHICAGO — When patients decide on the type of thyroidectomy procedure they will receive, they primarily weigh factors such as recurrent laryngeal nerve injury and mental nerve injury potential and cost, with younger patients also taking potential scarring into account, according to findings presented at the annual meeting of the American Thyroid Association.

CHICAGO — All-cause mortality risk is greater for adults aged at least 60 years with overt hypothyroidism compared with adults with euthyroidism, but the same is not true for cardiovascular mortality risk, according to findings presented at the annual meeting of the American Thyroid Association.

CHICAGO — Tall cell percentages between 30% and 49% appeared associated with higher tumor aggressiveness among patients with papillary thyroid carcinoma, according to study results presented at the Annual Meeting of the American Thyroid Association.